Wang Jialin, Streja Elani, Rhee Connie M, Soohoo Melissa, Feng Mingliang, Brunelli Steven M, Kovesdy Csaba P, Gillen Daniel, Kalantar-Zadeh Kamyar, Chen Joline L T
School of Medicine, Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California Irvine, Orange, California; Division of Nephrology, Tianjin Union Medical Center, Tianjin, China.
School of Medicine, Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California Irvine, Orange, California.
J Ren Nutr. 2016 Jan;26(1):26-37. doi: 10.1053/j.jrn.2015.07.003. Epub 2015 Oct 21.
Lean body mass (LBM) represents the "fat-free" muscle mass in hemodialysis (HD) patients and is an important nutritional measure. Previous studies have found that both higher LBM and body mass index (BMI) were related to greater survival in HD patients. Additional studies have shown differences in survival across racial-ethnic groups of HD patients. However, the association of LBM and mortality across racial-ethnic subgroups has not been examined.
We hypothesize that racial differences in LBM affect the mortality in HD patients.
Chronic HD patients from a large dialysis organization in the United States.
Estimated LBM (eLBM), self-identified racial subgroups.
5-year survival.
We examined the association between baseline eLBM and survival using Cox proportional hazard models adjusted for demographics, comorbidities, and laboratory measures. Associations were examined across subgroups of race-ethnicity (non-Hispanic white, African American, and Hispanic) and BMI.
The final cohort included 117,683 HD patients, who were 62 ± 15 (mean ± standard deviation) years old, 43% women and 59% with diabetes mellitus. Higher eLBM was linearly associated with lower mortality. Compared with the reference group (48.4-<50.5 kg), patients with the lowest eLBM (<41.3 kg) had a 1.4-fold higher risk of mortality (hazard ratio: 1.37; 95% confidence interval: 1.30-1.44) in the fully adjusted model. A similar linear association was seen among patients with BMI < 35 kg/m(2) and in non-Hispanic whites and African American subgroups. However, higher eLBM was not associated with improved survival in Hispanic patients or patients with BMI ≥ 35 kg/m(2).
Potential residual confounding.
Higher eLBM is associated with a lower mortality risk in HD patients, especially among non-Hispanic white and African American groups. Hispanic patients do not demonstrate a similar inverse relationship. The association between LBM and mortality among different racial groups of HD patients deserves additional study.
瘦体重(LBM)代表血液透析(HD)患者的“无脂肪”肌肉量,是一项重要的营养指标。既往研究发现,较高的LBM和体重指数(BMI)均与HD患者更好的生存率相关。其他研究表明,HD患者的不同种族-族裔群体在生存率方面存在差异。然而,尚未研究LBM与不同种族-族裔亚组死亡率之间的关联。
我们假设LBM的种族差异会影响HD患者的死亡率。
来自美国一个大型透析机构的慢性HD患者。
估计的LBM(eLBM)、自我认定的种族亚组。
5年生存率。
我们使用经人口统计学、合并症和实验室指标调整的Cox比例风险模型,研究基线eLBM与生存率之间的关联。在种族-族裔亚组(非西班牙裔白人、非裔美国人和西班牙裔)和BMI亚组中研究这种关联。
最终队列包括117,683例HD患者,年龄为62±15(均值±标准差)岁,43%为女性,59%患有糖尿病。较高的eLBM与较低的死亡率呈线性相关。在完全调整模型中,与参照组(48.4 - <50.5 kg)相比,eLBM最低(<41.3 kg)的患者死亡风险高1.4倍(风险比:1.37;95%置信区间:1.30 - 1.44)。在BMI < 35 kg/m²的患者以及非西班牙裔白人和非裔美国人亚组中也观察到类似的线性关联。然而,较高的eLBM与西班牙裔患者或BMI≥35 kg/m²的患者生存率改善无关。
潜在的残余混杂因素。
较高的eLBM与HD患者较低的死亡风险相关,尤其是在非西班牙裔白人和非裔美国人群体中。西班牙裔患者未表现出类似的反向关系。HD患者不同种族群体中LBM与死亡率之间的关联值得进一步研究。